# Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

> **NCT04766398** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 169 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** KHK7791
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04766398
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2021-09-27
- **Final completion:** 2021-09-27
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766398, "Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04766398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*